Stock Analysis on Net
Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Debt to Equity
since 2005

Microsoft Excel

Calculation

Biogen Inc., debt to equity, long-term trends, calculation

Microsoft Excel
Debt to equity = Notes payable1 ÷ Total Biogen Inc. shareholders’ equity1
Dec 31, 2021 0.67 = 7,273,100 ÷ 10,896,200
Dec 31, 2020 0.69 = 7,426,200 ÷ 10,700,300
Dec 31, 2019 0.45 = 5,954,800 ÷ 13,343,200
Dec 31, 2018 0.46 = 5,936,500 ÷ 13,039,600
Dec 31, 2017 0.47 = 5,938,200 ÷ 12,612,800
Dec 31, 2016 0.54 = 6,517,400 ÷ 12,140,100
Dec 31, 2015 0.70 = 6,526,300 ÷ 9,372,800
Dec 31, 2014 0.05 = 585,197 ÷ 10,809,010
Dec 31, 2013 0.07 = 595,927 ÷ 8,620,242
Dec 31, 2012 0.16 = 1,140,775 ÷ 6,961,523
Dec 31, 2011 0.17 = 1,064,100 ÷ 6,425,499
Dec 31, 2010 0.22 = 1,203,532 ÷ 5,396,506
Dec 31, 2009 0.18 = 1,099,969 ÷ 6,221,530
Dec 31, 2008 0.19 = 1,113,098 ÷ 5,806,083
Dec 31, 2007 0.28 = 1,562,978 ÷ 5,534,295
Dec 31, 2006 0.01 = 96,694 ÷ 7,149,778
Dec 31, 2005 0.01 = 43,444 ÷ 6,905,876

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands

Comparison to Competitors

Biogen Inc., debt to equity, long-term trends, comparison to competitors

Microsoft Excel
Biogen Inc. AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Zoetis Inc.
Dec 31, 2021 0.67 4.98 4.97 1.24 0.49 1.88 1.27 0.46 0.87 0.50 0.14 0.85 1.45
Dec 31, 2020 0.69 6.58 3.51 1.34 0.53 2.94 1.73 0.56 1.26 0.63 0.24 0.63 1.91
Dec 31, 2019 0.45 — 3.09 0.91 0.72 5.88 1.09 0.47 1.02 0.83 0.06 0.60 2.38
Dec 31, 2018 0.46 — 2.71 0.52 0.35 1.30 1.28 0.51 0.94 0.66 0.08 0.69 2.95
Dec 31, 2017 0.47 7.33 1.40 0.68 0.40 1.18 1.64 0.57 0.71 0.60 0.11 0.83 2.80
Dec 31, 2016 0.54 7.95 1.16 0.41 0.53 0.74 1.39 0.39 0.62 0.71 0.11 0.77 3.00
Dec 31, 2015 0.70 8.03 1.12 0.47 0.54 0.55 1.20 0.28 0.59 0.60 0.10 0.59 4.56
Dec 31, 2014 0.05 8.62 1.19 0.53 0.15 0.52 0.80 0.27 0.44 0.51 0.18 0.71 2.78
Dec 31, 2013 0.07 3.28 1.45 0.55 0.16 0.30 0.58 0.25 0.50 0.48 0.26 0.62 3.89
Dec 31, 2012 0.16 4.66 1.39 0.54 0.28 0.37 0.88 0.25 0.39 0.46 0.37 0.46 0.14
Dec 31, 2011 0.17 — 1.13 0.34 0.31 0.52 1.13 0.34 0.32 0.47 0.90 0.47 —
Dec 31, 2010 0.22 — 0.56 0.35 0.21 0.56 0.59 0.30 0.33 0.50 0.31 0.14 —
Dec 31, 2009 0.18 — 0.47 0.43 0.25 0.70 0.18 0.29 0.30 0.54 0.27 0.14 —
Dec 31, 2008 0.19 — 0.50 0.55 0.27 1.55 0.31 0.28 0.33 0.30 0.00 0.14 —
Dec 31, 2007 0.28 — 0.63 0.59 0.41 0.37 0.38 0.22 0.32 0.20 0.43 0.15 —
Dec 31, 2006 0.01 — 0.48 0.74 0.37 0.34 0.77 0.17 0.39 0.11 0.92 0.19 —
Dec 31, 2005 0.01 — 0.19 0.77 0.21 0.60 0.10 0.07 0.45 0.27 1.75 0.21 —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Biogen Inc., debt to equity, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Biogen Inc. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2021 0.67 0.96
Dec 31, 2020 0.69 1.16
Dec 31, 2019 0.45 1.12
Dec 31, 2018 0.46 0.96
Dec 31, 2017 0.47 0.89
Dec 31, 2016 0.54 0.80
Dec 31, 2015 0.70 0.70
Dec 31, 2014 0.05 0.56
Dec 31, 2013 0.07 0.53
Dec 31, 2012 0.16 0.51
Dec 31, 2011 0.17 0.46
Dec 31, 2010 0.22 0.39
Dec 31, 2009 0.18 0.39
Dec 31, 2008 0.19 0.37
Dec 31, 2007 0.28 0.30
Dec 31, 2006 0.01 0.25
Dec 31, 2005 0.01 0.29

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Biogen Inc., debt to equity, long-term trends, comparison to industry (health care)

Microsoft Excel
Biogen Inc. Health Care
Dec 31, 2021 0.67 0.80
Dec 31, 2020 0.69 0.91
Dec 31, 2019 0.45 0.92
Dec 31, 2018 0.46 0.88
Dec 31, 2017 0.47 0.80
Dec 31, 2016 0.54 0.75
Dec 31, 2015 0.70 0.69
Dec 31, 2014 0.05 0.53
Dec 31, 2013 0.07 0.49
Dec 31, 2012 0.16 0.51
Dec 31, 2011 0.17 0.45
Dec 31, 2010 0.22 0.41
Dec 31, 2009 0.18 0.41
Dec 31, 2008 0.19 0.41
Dec 31, 2007 0.28 0.36
Dec 31, 2006 0.01 0.33
Dec 31, 2005 0.01 0.30

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).